Facilitators and Barriers to the Adoption of Telemedicine During the First Year of COVID-19: Systematic Review
Top Cited Papers
Open Access
- 4 January 2022
- journal article
- review article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 24 (1) , e31752
Abstract
Background: The virulent and unpredictable nature of COVID-19 combined with a change in reimbursement mechanisms both forced and enabled the rapid adoption of telemedicine around the world. Thus, it is important to now assess the effects of this rapid adoption and to determine whether the barriers to such adoption are the same today as they were under prepandemic conditions. Objective: The objective of this systematic literature review was to examine the research literature published during the COVID-19 pandemic to identify facilitators, barriers, and associated medical outcomes as a result of adopting telemedicine, and to determine if changes have occurred in the industry during this time. Methods: The systematic review was performed in accordance with the Kruse protocol and the results are reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We analyzed 46 research articles from five continents published during the first year of the COVID-19 pandemic that were retrieved from searches in four research databases: PubMed (MEDLINE), CINAHL, Science Direct, and Web of Science. Results: Reviewers identified 25 facilitator themes and observations, 12 barrier themes and observations, and 14 results (compared to a control group) themes and observations. Overall, 22% of the articles analyzed reported strong satisfaction or satisfaction (zero reported a decline in satisfaction), 27% reported an improvement in administrative or efficiency results (as compared with a control group), 14% reported no statistically significant difference from the control group, and 40% and 10% reported an improvement or no statistically significant difference in medical outcomes using the telemedicine modality over the control group, respectively. Conclusions: The pandemic encouraged rapid adoption of telemedicine, which also encouraged practices to adopt the modality regardless of the challenges identified in previous research. Several barriers remain for health policymakers to address; however, health care administrators can feel confident in the modality as the evidence largely shows that it is safe, effective, and widely accepted.Keywords
All Related Versions
This publication has 65 references indexed in Scilit:
- Impact of a Mobile Health Intervention on Long-term Nonadherence After Lung Transplantation: Follow-up After a Randomized Controlled TrialTransplantation, 2020
- Writing a Systematic Review for Publication in a Health-Related Degree ProgramJMIR Research Protocols, 2019
- PATHway-I: Feasibility, acceptability and clinical effectiveness of a technology enabled cardiac rehabilitation platform. A randomized controlled trial. (Preprint)Journal of Medical Internet Research, 2019
- Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-EfficacyDigestive Diseases and Sciences, 2019
- Impact of telemedicine on the clinical outcomes and healthcare costs of patients with chronic heart failure and mid-range or preserved ejection fraction managed in a multidisciplinary chronic heart failure programme: A sub-analysis of the iCOR randomized trialJournal of Telemedicine and Telecare, 2018
- Exploring the uptake and implementation of tele-monitored home-exercise programmes in adults with Parkinson’s disease: A mixed-methods pilot studyJournal of Telemedicine and Telecare, 2018
- Evaluating barriers to adopting telemedicine worldwide: A systematic reviewJournal of Telemedicine and Telecare, 2016
- Interrater reliability: the kappa statisticBiochemia Medica, 2012
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Measures of response agreement for qualitative data: Some generalizations and alternatives.Psychological Bulletin, 1971